Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?
Optimizing and standardizing susceptibility testing for the polymyxins have become pressing issues, given the rise in multidrug-resistant Gram-negative bacilli. Recently, both the CLSI and EUCAST have recommended broth microdilution (BMD) (without polysorbate) as the reference method for polymyxin s...
Saved in:
主要作者: | Vasoo, Shawn |
---|---|
其他作者: | Munson, Erik |
格式: | Article |
語言: | English |
出版: |
2018
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/87252 http://hdl.handle.net/10220/44372 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Clinical experience with high-dose polymyxin b against carbapenem-resistant gram-negative bacterial infections—a cohort study
由: Cai, Y., et al.
出版: (2021) -
Performance of population pharmacokinetic models in predicting polymyxin b exposures
由: Tam, V.H., et al.
出版: (2021) -
One step forward, two steps back : the fable of media liberalisation in Singapore
由: Ng, Sherry Yun Feng, et al.
出版: (2008) -
Interaction of the Antimicrobial Peptide Polymyxin B1 with Both Membranes of E. coli: A Molecular Dynamics Study
由: Berglund N.A., et al.
出版: (2019) -
Two steps forward, one step back? An attempt to cure due process paranoia
由: LAU, Louis Yi Hang
出版: (2021)